EROSIVE STRUCTURAL CHANGES AND THE IMPACT OF ANTI-TNFA THERAPY IN THE SPINE OF PATIENTS WITH ANKYLOSING SPONDYLITIS

被引：0
|
作者：
Baraliakos, X. [1 ]
Listing, J. [2 ]
Rudwaleit, M. [3 ]
Sieper, J. [3 ]
Braun, J. [1 ]
机构：
[1] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, D-4690 Herne, Germany
[2] German Rheumatism Res Ctr, Berlin, Germany
[3] Univ Med Berlin, Dept Rheumatol, Berlin, Germany
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2010年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：606 / 607
页数：2
相关论文
共 50 条
  • [1] Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFa drugs and therapy-induced changes
    Niccoli, Laura
    Nannini, Carlotta
    Cassara, Emanuele
    Kaloudi, Olga
    Cantini, Fabrizio
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2012, 15 (01) : 56 - 61
  • [2] Which Rheumatoid Arthritis, Ankylosing Spondylitis and Juvenile Idiopathic Arthritis Patients Initiate Anti-TNFa Therapy?
    Saraux, Alain
    Benichou, Jacques
    Deslandre, Chantal
    Guillevin, Loic
    Idbrik, Latifa
    Sibilia, Jean
    Soudan, Marc
    Wendling, Daniel
    Guillemin, Francis
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S781 - S781
  • [3] The incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to anti-TNFA therapy
    Braun, J.
    Baraliakos, X.
    Listing, J.
    Davis, J.
    Van der Heijde, D.
    Haibel, H.
    Rudwaleit, M.
    Sieper, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 86 - 86
  • [4] Persistent clinical efficacy and safety of infliximab in patients with ankylosing spondylitis over 7 years - Evidence for different response to anti-TNFA therapy
    Baraliakos, X.
    Listing, J.
    Burmester, G.
    Krause, A.
    Schewe, S.
    Schneider, M.
    Soerensen, H.
    Zeidler, H.
    Sieper, J.
    Braun, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 746 - 746
  • [5] Two Cases of Optic Neuritis Under Golimumab Therapy (Anti-TNFa) for Ankylosing Spondylitis Reveling Central Demyelinating Disorders
    Maucorps, C.
    Chawadronow, V.
    Branger, P.
    Derache, N.
    Fedrizzi, S.
    Defer, G.
    DRUG SAFETY, 2017, 40 (10) : 975 - 976
  • [6] Paradoxical Psoriasis Secondary to Anti-Tnfa Agents in Patients with Ankylosing Spondylitis: A Nationwide Population-Based Cohort Study
    Kim, Ki-Jo
    Bae, Jung Min
    Bin Joo, Young
    Baek, In-Woon
    Park, Kyung-Su
    Cho, Chul-Soo
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [7] Persistent clinical response in patients with ankylosing spondylitis after 4 years of treatment with the anti-TNFa monoclonal antibody infliximab
    Baraliakos, X
    Listing, J
    Brandt, J
    Alten, R
    Burmester, G
    Gromnika-Ihle, E
    Kellner, H
    Schneider, M
    Soerensen, H
    Zeidler, H
    Haibel, H
    Rudwaleit, M
    Sieper, J
    Braun, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 322 - +
  • [8] A major subset of ankylosing spondylitis patients require anti-TNFA biological treatments in a tertiary clinical care with the current guidelines
    Temel, M
    Atagunduz, P
    Direskeneli, H
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 407 - 407
  • [9] Persistent clinical efficacy and excellent safety over 5 years of treatment with the anti-TNFA agent infliximab in patients with ankylosing spondylitis
    Baraliakos, X.
    Listing, J.
    Brandt, J.
    Alten, R.
    Burmester, G.
    Gromnica-Ihle, E.
    Schewe, S.
    Schneider, M.
    Soerensen, H.
    Zeidler, H.
    Haibel, H.
    Sieper, J.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 206 - 206
  • [10] EVALUATION OF QUALITY OF LIFE IN IBD PATIENTS TREATED WITH ANTI-TNFA THERAPY
    Lorenzon, G.
    Caccaro, R.
    Girardin, G.
    Barberio, B.
    Rigo, A.
    Savarino, E. V.
    Sturniolo, G. C.
    D'Inca, R.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E141 - E142
12345